Delta Financial Group, Inc. Novo Nordisk A S Transaction History

Delta Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$102.11 - $135.92 $323,178 - $430,186	-3,165 Reduced 12.57%	22,019 $2.83 Million
Q4 2023 Jan 18, 2024	BUY	$87.78 - $105.45 $4,389 - $5,272	50 Added 0.2%	25,184 $2.61 Million
Q3 2023 Oct 31, 2023	BUY	$90.94 - $199.54 $2.29 Million - $5.02 Million	25,134 New	25,134 $2.29 Million
Q1 2023 Apr 25, 2023	BUY	$132.34 - $159.14 $8,072 - $9,707	61 Added 0.49%	12,557 $2 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $1.28 Million - $1.69 Million	12,496 New	12,496 $1.67 Million

1,988

318M

5.16M

4.97M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $260B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Delta Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Delta Financial Group, Inc. with notifications on news.